Keyphrases
Gene Expression
100%
Cell Culture Model
100%
Gene Fusion
100%
Hormone-sensitive Prostate Cancer
100%
Fusion Gene
100%
Chemoresponsiveness
100%
Transmembrane Protease Serine 2 (TMPRSS2)
100%
ETS-related Gene
100%
Radioresponsiveness
100%
Radiosensitivity
36%
Gene-gene
27%
DU145
27%
Chemosensitivity
27%
ETS Transcription Factors
18%
PC-3 Cells
18%
DNA Repair
9%
Signaling Pathway
9%
Recurrent Disease
9%
Clinical Samples
9%
Microarray Analysis
9%
Post-irradiation
9%
DNA Double-strand Breaks
9%
Prostate Tumor Cells
9%
Differential Gene Expression
9%
Prognostic Factors
9%
Paclitaxel
9%
Androgens
9%
Path Analysis
9%
Radiation Sensitivity
9%
Radio
9%
Stably Expressing
9%
Mitosis
9%
X-ray Irradiation
9%
PC-3 Cell Line
9%
Phenotypic Expression
9%
Tumor Cell Lines
9%
Gene Expression Changes
9%
DNA Breaks
9%
Prostatectomy
9%
Tumor Proliferation
9%
Pathway Studio
9%
Fusion Gene Transcripts
9%
Paclitaxel Sensitivity
9%
Gene Type
9%
Aggressive Phenotype
9%
Transmembrane Protease
9%
Clonogenic Survival
9%
Pathway Interaction
9%
Ariadne
9%
Medicine and Dentistry
Gene Expression
100%
Prostate Cancer
100%
Cell Culture
100%
Gene Fusion
100%
Androgen
100%
Fusion Gene
100%
Radiosensitivity
62%
Chemosensitivity
37%
Transcription Factors
25%
Paclitaxel
25%
Recurrent Disease
12%
Cell Cycle
12%
Cell Line
12%
Downregulation
12%
Upregulation
12%
Tumor Progression
12%
DNA Repair
12%
Cell Signaling Pathway
12%
Microarray Analysis
12%
Prostate Tumor
12%
Differential Gene Expression
12%
Prognostic Factor
12%
Cell Fusion
12%
X Irradiation
12%
Tumor Cell Line
12%
Prostatectomy
12%
DU145 Cell Line
12%
Serine Proteinase
12%
Double-Strand DNA Break
12%